Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Synthetic heart graft patient reaches milestone:

This article was originally published in Clinica

Executive Summary

CardioTech International says that the first recipient of its investigational synthetic coronary artery bypass graft, CardioPass, has reached the one-year mark. The female patient, who had been considered a "no option" patient because she had no usable mammary artery, received the implant in Brazil in August 2003. She is currently leading a normal life, is asymptomatic and has no cardiac pain, said the Wilmington, Massachusetts firm. Her blood pressure and EKG are also both normal. In addition, two further patients who received the implant last year are also leading normal lives. CardioPass is designed to obviate the need for vessel harvesting surgery. CardioTech estimates the annual worldwide market for the synthetic graft will be in excess of $1bn.

You may also be interested in...

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.


ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

Start-Up Snapshot: Nanomedic’s Electro-Spinning, Portable Wound Care Device

At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts